FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025101604> ?p ?o ?g. }

• W2025101604 endingPage "1036" @default.
• W2025101604 startingPage "1030" @default.
• W2025101604 abstract "O6-benzylguanine (O6-BG) and 3-aminobenzamide (3-AB) inhibit the DNA repair proteins O6-alkylguanine-DNA alkyltransferase (AGT) and poly(ADP-ribose) polymerase (PARP) respectively. The effect of O6-BG and/or 3-AB on temozolomide and 1,3-bis(2-chloroethyl)-nitrosourea (BCNU) cytotoxicity, was assessed in seven human tumour cell lines: six with an AGT activity of > 80 fmol mg-1 protein (Mer+) and one with an AGT activity of < 3 fmol mg-1 protein (Mer-). Three of the Mer+ cell lines (LS174T, DLD1 and HCT116) were considered to exhibit resistance to methylation by a mismatch repair deficiency (MMR-), each being known to exhibit microsatellite instability, and DLD1 and HCT116 having well-characterised defects in DNA mismatch binding. Potentiation was defined as the ratio between an IC50 achieved without and with a particular inhibitor treatment. Temozolomide or BCNU cytotoxicity was not potentiated by either inhibitor in the Mer- cell line. Preincubation with O6-BG (100 microM for 1 h) was found to potentiate the cytotoxicity of temozolomide by 1.35- to 1.57-old in Mer+/MMR+ cells, but had no significant effect in Mer+/MMR- cells. In comparison, O6-BG pretreatment enhanced BCNU cytotoxicity by 1.94- to 2.57-fold in all Mer+ cell lines. Post-incubation with 3-AB (2 mM, 48 h) potentiated temozolomide by 1.35- to 1.59-fold in Mer+/MMR+ cells, and when combined with O6-BG pretreatment produced an effect which was at least additive, enhancing cytotoxicity by 1.97- to 2.16-fold. 3-AB treatment also produced marked potentiation (2.20- to 3.12-fold) of temozolomide cytotoxicity in Mer+/MMR- cells. In contrast, 3-AB produced marginal potentiation of BCNU cytotoxicity in only three cell lines (1.19- to 1.35-fold), and did not enhance the cytotoxicity of BCNU with O6-BG treatment in any cell line. These data suggest that the combination of an AGT and PARP inhibitor may have a therapeutic role in potentiating temozolomide activity, but that the inhibition of poly(ADP-ribosyl)ation has little effect on the cytotoxicity of BCNU." @default.
• W2025101604 created "2016-06-24" @default.
• W2025101604 creator A5023805008 @default.
• W2025101604 creator A5088521257 @default.
• W2025101604 creator A5090902252 @default.
• W2025101604 date "1996-10-01" @default.
• W2025101604 modified "2023-10-09" @default.
• W2025101604 title "3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity" @default.
• W2025101604 cites W101475269 @default.
• W2025101604 cites W1513191136 @default.
• W2025101604 cites W1516722054 @default.
• W2025101604 cites W1519629930 @default.
• W2025101604 cites W1537425172 @default.
• W2025101604 cites W1593197699 @default.
• W2025101604 cites W1600561912 @default.
• W2025101604 cites W1636514590 @default.
• W2025101604 cites W1637771339 @default.
• W2025101604 cites W1667524449 @default.
• W2025101604 cites W1669292210 @default.
• W2025101604 cites W1847864430 @default.
• W2025101604 cites W1907545229 @default.
• W2025101604 cites W1935459338 @default.
• W2025101604 cites W1963973703 @default.
• W2025101604 cites W1970184435 @default.
• W2025101604 cites W1971921783 @default.
• W2025101604 cites W1972562299 @default.
• W2025101604 cites W1975590894 @default.
• W2025101604 cites W1976209111 @default.
• W2025101604 cites W1977492313 @default.
• W2025101604 cites W1978871519 @default.
• W2025101604 cites W1979520139 @default.
• W2025101604 cites W1980195588 @default.
• W2025101604 cites W1991901736 @default.
• W2025101604 cites W2007697951 @default.
• W2025101604 cites W2012732208 @default.
• W2025101604 cites W2018346130 @default.
• W2025101604 cites W2018809925 @default.
• W2025101604 cites W2020382083 @default.
• W2025101604 cites W2031694870 @default.
• W2025101604 cites W2038011235 @default.
• W2025101604 cites W2040825579 @default.
• W2025101604 cites W2043229259 @default.
• W2025101604 cites W2050321855 @default.
• W2025101604 cites W2053701783 @default.
• W2025101604 cites W2059888592 @default.
• W2025101604 cites W2060251624 @default.
• W2025101604 cites W2060348944 @default.
• W2025101604 cites W2064700784 @default.
• W2025101604 cites W2076176285 @default.
• W2025101604 cites W2077559325 @default.
• W2025101604 cites W2077945404 @default.
• W2025101604 cites W2078073022 @default.
• W2025101604 cites W2079203845 @default.
• W2025101604 cites W2079786467 @default.
• W2025101604 cites W2080028600 @default.
• W2025101604 cites W2084097122 @default.
• W2025101604 cites W2089857550 @default.
• W2025101604 cites W2092807015 @default.
• W2025101604 cites W2095277286 @default.
• W2025101604 cites W2099594706 @default.
• W2025101604 cites W2109549713 @default.
• W2025101604 cites W2109689528 @default.
• W2025101604 cites W2111989254 @default.
• W2025101604 cites W2114539716 @default.
• W2025101604 cites W2128635872 @default.
• W2025101604 cites W2136498171 @default.
• W2025101604 cites W2140383812 @default.
• W2025101604 cites W2144322094 @default.
• W2025101604 cites W2157243644 @default.
• W2025101604 cites W2166300852 @default.
• W2025101604 cites W2333175709 @default.
• W2025101604 cites W2407104316 @default.
• W2025101604 cites W2436679225 @default.
• W2025101604 cites W3101551598 @default.
• W2025101604 cites W1482489382 @default.
• W2025101604 doi "https://doi.org/10.1038/bjc.1996.485" @default.
• W2025101604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2077105" @default.
• W2025101604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8855970" @default.
• W2025101604 hasPublicationYear "1996" @default.
• W2025101604 type Work @default.
• W2025101604 sameAs 2025101604 @default.
• W2025101604 citedByCount "114" @default.
• W2025101604 countsByYear W20251016042012 @default.
• W2025101604 countsByYear W20251016042013 @default.
• W2025101604 countsByYear W20251016042014 @default.
• W2025101604 countsByYear W20251016042015 @default.
• W2025101604 countsByYear W20251016042016 @default.
• W2025101604 countsByYear W20251016042017 @default.
• W2025101604 countsByYear W20251016042018 @default.
• W2025101604 countsByYear W20251016042019 @default.
• W2025101604 countsByYear W20251016042020 @default.
• W2025101604 countsByYear W20251016042021 @default.
• W2025101604 countsByYear W20251016042022 @default.
• W2025101604 crossrefType "journal-article" @default.
• W2025101604 hasAuthorship W2025101604A5023805008 @default.
• W2025101604 hasAuthorship W2025101604A5088521257 @default.
• W2025101604 hasAuthorship W2025101604A5090902252 @default.
• W2025101604 hasBestOaLocation W20251016041 @default.

• next